Literature DB >> 16257543

Overview of avian influenza DIVA test strategies.

David L Suarez1.   

Abstract

The use of vaccination in poultry to control avian influenza has been increasing in recent years. Vaccination has been primarily with killed whole virus-adjuvanted vaccines. Proper vaccination can reduce or prevent clinical signs, reduce virus shedding in infected birds, and increase the resistance to infection. Historically, one limitation of the killed vaccines is that vaccinated birds cannot be differentiated serologically from naturally infected birds using the commonly available diagnostic tests. Therefore, surveillance for avian influenza becomes much more difficult and often results in trade restrictions because of the inability to differentiate infected from vaccinated animals (DIVA). Several different DIVA strategies have been proposed for avian influenza to overcome this limitation. The most common is the use of unvaccinated sentinels. A second approach is the use of subunit vaccines targeted to the hemagglutinin protein that allows serologic surveillance to the internal proteins. A third strategy is to vaccinate with a homologous hemagglutinin to the circulating field strain, but a heterologous neuraminidase subtype. Serologic surveillance can then be performed for the homologous NA subtype as evidence of natural infection. The fourth strategy is to measure the serologic response to the nonstructural protein 1 (NS1). The NS1 protein is produced in large quantities in infected cells, but it is not packaged in the virion. Since killed vaccines for influenza are primarily made with whole virions, a differential antibody response can be seen between naturally infected and vaccinated animals. However, poultry vaccines are not highly purified, and they contain small amounts of the NS1 protein. Although vaccinated chickens will produce low levels of antibody to the NS1 protein, virus infected chickens will produce higher levels of NS1 antibody, and the two groups can be differentiated. All four DIVA strategies have advantages and disadvantages, and further testing is needed to identify the best strategy to make vaccination a more viable option for avian influenza.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257543     DOI: 10.1016/j.biologicals.2005.08.003

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  23 in total

1.  Field application of the H9M2e enzyme-linked immunosorbent assay for differentiation of H9N2 avian influenza virus-infected chickens from vaccinated chickens.

Authors:  Min-Chul Kim; Jun-Gu Choi; Ji-Sun Kwon; Hyun-Mi Kang; Mi-Ra Paek; Ok-Mi Jeong; Jun-Hun Kwon; Youn-Jeong Lee
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

2.  H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.

Authors:  Dong-Hun Lee; Jae-Keun Park; Yu-Na Lee; Jae-Min Song; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Vaccine       Date:  2011-04-02       Impact factor: 3.641

3.  Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.

Authors:  Katherine A Richards; Francisco A Chaves; Shabnam Alam; Andrea J Sant
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

4.  Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro.

Authors:  Wai-Hong Wu; Andrew Pekosz
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  A Bayesian approach to quantifying the effects of mass poultry vaccination upon the spatial and temporal dynamics of H5N1 in Northern Vietnam.

Authors:  Patrick G T Walker; Simon Cauchemez; Raphaëlle Métras; Do Huu Dung; Dirk Pfeiffer; Azra C Ghani
Journal:  PLoS Comput Biol       Date:  2010-02-19       Impact factor: 4.475

6.  A framework for evaluating animals as sentinels for infectious disease surveillance.

Authors:  Jo E B Halliday; Anna L Meredith; Darryn L Knobel; Darren J Shaw; Barend M de C Bronsvoort; Sarah Cleaveland
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

7.  The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).

Authors:  Pamela Galvin; Sarah Gildea; Sean Arkins; Cathal Walsh; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2013-12       Impact factor: 4.380

Review 8.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

9.  Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice.

Authors:  Srinivas Rao; Wing-Pui Kong; Chih-Jen Wei; Zhi-Yong Yang; Martha Nason; Darrel Styles; Louis J DeTolla; Aruna Panda; Erin M Sorrell; Haichen Song; Hongquan Wan; Gloria C Ramirez-Nieto; Daniel Perez; Gary J Nabel
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.